Investing Profile

Raphael Wisniewski

InvestorVC
Associate at Andera Partners
Photo of Raphael Wisniewski, Associate at Andera Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Andera Partners Associate
$5.0M - $35.0M
$20.0M
17
CompanyStageDateRound SizeTotal Raised
EG 427
Series BFeb 2025$28M
$28M
ENYO Pharma
Series CJan 2024$28M
Series BJun 2018$47M
$75M
Co-investors: Carl Gordon (OrbiMed), Iain Dukes (OrbiMed)
Andera Partners
Series AApr 2023$49M
$49M
BioVentrix
Series AApr 2023$49M
$49M
SoniVie
Series CJan 2023$60M
$60M
Amolyt Pharma
Series CJan 2023$140M
$290M
Co-investors: Felice Verduyn - van Weegen (EQT Life Sciences), Iyona Rajkomar (Pontifax Venture Capital), Thierry Laugel (Kurma Partners), Ohad Hammer (Pontifax Venture Capital)
ImCheck Therapeutics
Series CJun 2022$100M
$180M
Co-investors: Dr. Regina Hodits (Wellington Partners), Florent Gros (Earlybird Venture Capital), Michael Baran (Pfizer Venture Investments), Rémi Droller (Kurma Partners), Klaus Breiner (Pureos Bioventures), Vincent Brichard
Exciva
Series AOct 2021$10M
$10M
Co-investors: Sofia Ioannidou (Andera Partners)